Illumina Inc (ILMN)

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Industry: Laboratory Analytical Instruments (SIC 3826)

Market region: US

Address: 5200 Illumina Way, San Diego, CA, 92122

Market capitalization

32.23 billion USD (32,225,256,000 USD)

Listing date

07/28/2000

Weighted shares outstanding

151,200,000

Share class shares outstanding

151,200,000

https://www.illumina.com